Associations between essential medicines and health outcomes for cardiovascular disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Associations between essential medicines and health outcomes for cardiovascular disease ; volume:21 ; number:1 ; day:25 ; month:3 ; year:2021 ; pages:1-12 ; date:12.2021
BMC cardiovascular disorders ; 21, Heft 1 (25.3.2021), 1-12, 12.2021
- Urheber
-
Steiner, Liane
Fraser, Shawn
Maraj, Darshanand
Persaud, Nav
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-021-01955-1
- URN
-
urn:nbn:de:101:1-2021050919453162305698
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:05 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Steiner, Liane
- Fraser, Shawn
- Maraj, Darshanand
- Persaud, Nav
- SpringerLink (Online service)
Ähnliche Objekte (12)
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Changes in essential cancer medicines and association with cancer outcomes: an observational study of 158 countries
Availability, price and affordability of essential medicines for managing cardiovascular disease in Addis Ababa, Ethiopia
Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal
Improving quality of essential medicines : a biowaiver approach
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Revising the WHO Essential Medicines List for paediatric rheumatology
Biologic medicine inclusion in 138 national essential medicines lists
Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries
Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Changes in essential cancer medicines and association with cancer outcomes: an observational study of 158 countries
Availability, price and affordability of essential medicines for managing cardiovascular disease in Addis Ababa, Ethiopia
Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal
Improving quality of essential medicines : a biowaiver approach
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Revising the WHO Essential Medicines List for paediatric rheumatology
Biologic medicine inclusion in 138 national essential medicines lists
Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries
Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Changes in essential cancer medicines and association with cancer outcomes: an observational study of 158 countries
Availability, price and affordability of essential medicines for managing cardiovascular disease in Addis Ababa, Ethiopia
Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal
Improving quality of essential medicines : a biowaiver approach
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Revising the WHO Essential Medicines List for paediatric rheumatology
Biologic medicine inclusion in 138 national essential medicines lists
Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries